JB Capital LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG

JB Capital LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 459 shares of the medical equipment provider’s stock after purchasing an additional 47 shares during the period. JB Capital LLC’s holdings in Intuitive Surgical were worth $249,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Blue Trust Inc. lifted its position in shares of Intuitive Surgical by 7.6% in the 2nd quarter. Blue Trust Inc. now owns 5,230 shares of the medical equipment provider’s stock worth $2,842,000 after purchasing an additional 368 shares during the period. Monument Capital Management bought a new position in shares of Intuitive Surgical in the 2nd quarter worth about $245,000. Cyndeo Wealth Partners LLC increased its stake in shares of Intuitive Surgical by 5.3% in the 2nd quarter. Cyndeo Wealth Partners LLC now owns 10,227 shares of the medical equipment provider’s stock worth $5,557,000 after acquiring an additional 514 shares in the last quarter. Galvin Gaustad & Stein LLC increased its stake in shares of Intuitive Surgical by 29.4% in the 2nd quarter. Galvin Gaustad & Stein LLC now owns 1,319 shares of the medical equipment provider’s stock worth $717,000 after acquiring an additional 300 shares in the last quarter. Finally, Pinion Investment Advisors LLC increased its stake in shares of Intuitive Surgical by 41.6% in the 2nd quarter. Pinion Investment Advisors LLC now owns 2,252 shares of the medical equipment provider’s stock worth $1,224,000 after acquiring an additional 662 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 over the last 90 days. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Down 3.2%

NASDAQ:ISRG opened at $429.59 on Friday. The business’s 50-day simple moving average is $458.68 and its two-hundred day simple moving average is $497.98. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market cap of $154.00 billion, a PE ratio of 59.91, a P/E/G ratio of 4.66 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the previous year, the firm earned $1.78 EPS. The firm’s revenue was up 21.4% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday. Royal Bank Of Canada reissued an “outperform” rating and set a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Finally, Piper Sandler reissued an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $589.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.